Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gynecology | 21 | 2024 | 513 | 2.520 |
Why?
|
Obstetrics | 20 | 2024 | 658 | 2.190 |
Why?
|
Education, Medical, Undergraduate | 16 | 2022 | 1008 | 1.450 |
Why?
|
Professional Autonomy | 2 | 2019 | 177 | 1.230 |
Why?
|
Curriculum | 20 | 2022 | 3605 | 0.930 |
Why?
|
Clinical Clerkship | 7 | 2020 | 532 | 0.850 |
Why?
|
Teaching | 7 | 2023 | 1174 | 0.800 |
Why?
|
Internship and Residency | 8 | 2024 | 5788 | 0.690 |
Why?
|
Radiation Protection | 1 | 2022 | 419 | 0.660 |
Why?
|
Education, Medical | 8 | 2021 | 1721 | 0.630 |
Why?
|
Trust | 2 | 2019 | 505 | 0.620 |
Why?
|
Schools, Medical | 9 | 2022 | 880 | 0.610 |
Why?
|
Gynecologic Surgical Procedures | 2 | 2019 | 336 | 0.600 |
Why?
|
Clinical Competence | 7 | 2022 | 4687 | 0.600 |
Why?
|
Faculty, Medical | 6 | 2020 | 1181 | 0.580 |
Why?
|
Wakefulness | 1 | 2023 | 1245 | 0.560 |
Why?
|
Students, Medical | 10 | 2022 | 1862 | 0.560 |
Why?
|
Embryo Loss | 1 | 2015 | 59 | 0.540 |
Why?
|
Education, Premedical | 1 | 2015 | 19 | 0.530 |
Why?
|
Professional Competence | 3 | 2015 | 447 | 0.500 |
Why?
|
Social Identification | 1 | 2015 | 103 | 0.490 |
Why?
|
Specialties, Surgical | 1 | 2019 | 391 | 0.480 |
Why?
|
Genital Neoplasms, Female | 3 | 2019 | 523 | 0.380 |
Why?
|
Self Concept | 1 | 2015 | 1025 | 0.340 |
Why?
|
Radiology | 1 | 2022 | 2100 | 0.320 |
Why?
|
Pregnancy Complications, Neoplastic | 3 | 2005 | 255 | 0.320 |
Why?
|
Counseling | 1 | 2015 | 1523 | 0.300 |
Why?
|
Vaginal Neoplasms | 2 | 2004 | 106 | 0.280 |
Why?
|
Hysterectomy | 2 | 2009 | 927 | 0.240 |
Why?
|
Attitude of Health Personnel | 4 | 2019 | 3843 | 0.230 |
Why?
|
Laparoscopy | 2 | 2019 | 2151 | 0.220 |
Why?
|
Multimedia | 1 | 2022 | 77 | 0.210 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2021 | 64 | 0.200 |
Why?
|
California | 6 | 2009 | 1402 | 0.190 |
Why?
|
Educational Measurement | 4 | 2020 | 1210 | 0.180 |
Why?
|
Endometrial Neoplasms | 1 | 2009 | 1353 | 0.180 |
Why?
|
Licensure, Medical | 1 | 2020 | 62 | 0.180 |
Why?
|
Personnel Selection | 1 | 2021 | 189 | 0.160 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 561 | 0.160 |
Why?
|
Abortion, Induced | 1 | 2024 | 458 | 0.160 |
Why?
|
Education, Distance | 1 | 2021 | 251 | 0.150 |
Why?
|
Ovarian Neoplasms | 4 | 2021 | 4838 | 0.150 |
Why?
|
Cultural Diversity | 1 | 2021 | 359 | 0.150 |
Why?
|
Preceptorship | 1 | 2018 | 61 | 0.150 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5319 | 0.150 |
Why?
|
Thinking | 1 | 2020 | 319 | 0.150 |
Why?
|
Physicians | 1 | 2016 | 4567 | 0.150 |
Why?
|
Carcinoma, Small Cell | 1 | 2020 | 420 | 0.150 |
Why?
|
Hypercalcemia | 1 | 2020 | 409 | 0.150 |
Why?
|
Problem-Based Learning | 1 | 2020 | 361 | 0.150 |
Why?
|
Financing, Personal | 1 | 2019 | 308 | 0.140 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 736 | 0.140 |
Why?
|
Humans | 49 | 2024 | 744343 | 0.140 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2005 | 2020 | 0.140 |
Why?
|
Students, Premedical | 1 | 2015 | 3 | 0.130 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1038 | 0.130 |
Why?
|
Mentors | 2 | 2018 | 631 | 0.130 |
Why?
|
Operating Rooms | 2 | 2019 | 817 | 0.120 |
Why?
|
Learning | 5 | 2022 | 1713 | 0.120 |
Why?
|
DNA Helicases | 1 | 2020 | 859 | 0.120 |
Why?
|
Emotional Intelligence | 1 | 2015 | 136 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2021 | 1226 | 0.110 |
Why?
|
Models, Educational | 1 | 2015 | 377 | 0.110 |
Why?
|
Ethics, Professional | 1 | 2013 | 102 | 0.110 |
Why?
|
Pelvic Neoplasms | 2 | 2005 | 254 | 0.110 |
Why?
|
Catechols | 1 | 2011 | 61 | 0.100 |
Why?
|
Echinocandins | 1 | 2011 | 45 | 0.100 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1788 | 0.100 |
Why?
|
Female | 26 | 2024 | 380194 | 0.100 |
Why?
|
Physical Examination | 1 | 2016 | 1237 | 0.090 |
Why?
|
Uterine Neoplasms | 1 | 2020 | 1513 | 0.090 |
Why?
|
Pregnancy | 8 | 2024 | 29144 | 0.090 |
Why?
|
Medical Oncology | 1 | 2002 | 2265 | 0.090 |
Why?
|
Socialization | 1 | 2010 | 87 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1534 | 0.090 |
Why?
|
Carcinogens | 1 | 2011 | 466 | 0.090 |
Why?
|
Cost of Illness | 1 | 2019 | 1859 | 0.090 |
Why?
|
Staff Development | 1 | 2011 | 223 | 0.080 |
Why?
|
United States | 10 | 2020 | 69872 | 0.080 |
Why?
|
Complementary Therapies | 1 | 2012 | 486 | 0.080 |
Why?
|
Sarcoma | 1 | 2020 | 1897 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2214 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2004 | 4034 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4479 | 0.080 |
Why?
|
History, 20th Century | 1 | 2016 | 2740 | 0.080 |
Why?
|
Postoperative Complications | 1 | 2009 | 15295 | 0.070 |
Why?
|
Palliative Care | 1 | 2002 | 3493 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2015 | 4468 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2005 | 9239 | 0.070 |
Why?
|
Health Expenditures | 1 | 2019 | 2348 | 0.070 |
Why?
|
Documentation | 1 | 2012 | 871 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3022 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3887 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5853 | 0.060 |
Why?
|
Physician-Patient Relations | 2 | 2015 | 3229 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1504 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2015 | 13989 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 2872 | 0.060 |
Why?
|
Neoplasm Staging | 3 | 2009 | 11031 | 0.060 |
Why?
|
Physician's Role | 1 | 2010 | 943 | 0.060 |
Why?
|
Lymph Node Excision | 1 | 2009 | 1261 | 0.060 |
Why?
|
Fetal Death | 1 | 2005 | 448 | 0.060 |
Why?
|
School Admission Criteria | 1 | 2024 | 105 | 0.050 |
Why?
|
Interleukin-21 Receptor alpha Subunit | 1 | 2021 | 18 | 0.050 |
Why?
|
Students | 2 | 2022 | 1654 | 0.050 |
Why?
|
Job Application | 1 | 2021 | 39 | 0.050 |
Why?
|
Test Taking Skills | 1 | 2020 | 10 | 0.050 |
Why?
|
Internet | 1 | 2013 | 3064 | 0.050 |
Why?
|
Quality Improvement | 1 | 2015 | 3749 | 0.050 |
Why?
|
Transcription Factors | 1 | 2020 | 12208 | 0.040 |
Why?
|
Carcinoma in Situ | 1 | 2005 | 806 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2214 | 0.040 |
Why?
|
Male | 6 | 2024 | 350118 | 0.040 |
Why?
|
Cancer Care Facilities | 1 | 2002 | 402 | 0.040 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2003 | 604 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 386 | 0.040 |
Why?
|
Adult | 10 | 2020 | 214055 | 0.040 |
Why?
|
Medical Records | 1 | 2004 | 1413 | 0.040 |
Why?
|
Pregnancy Outcome | 2 | 2005 | 2795 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2020 | 77449 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2021 | 1341 | 0.040 |
Why?
|
Intergenerational Relations | 1 | 2017 | 68 | 0.040 |
Why?
|
Prognosis | 3 | 2020 | 29063 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 25043 | 0.030 |
Why?
|
Brachytherapy | 1 | 2004 | 1248 | 0.030 |
Why?
|
Research Design | 1 | 2011 | 5987 | 0.030 |
Why?
|
Cohort Studies | 4 | 2020 | 40561 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1915 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2004 | 3616 | 0.030 |
Why?
|
Infant, Premature | 1 | 2005 | 2044 | 0.030 |
Why?
|
Survival Rate | 1 | 2009 | 12788 | 0.030 |
Why?
|
Endometriosis | 1 | 2003 | 839 | 0.030 |
Why?
|
Middle Aged | 8 | 2020 | 213383 | 0.030 |
Why?
|
Self Report | 2 | 2019 | 3558 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2004 | 8642 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1147 | 0.030 |
Why?
|
Computer-Assisted Instruction | 1 | 2017 | 365 | 0.030 |
Why?
|
Aged | 6 | 2019 | 163280 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2001 | 906 | 0.030 |
Why?
|
Learning Curve | 1 | 2015 | 208 | 0.030 |
Why?
|
Survival Analysis | 2 | 2004 | 10252 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39050 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2021 | 11483 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1270 | 0.030 |
Why?
|
Obstetrics and Gynecology Department, Hospital | 1 | 2012 | 43 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2012 | 57776 | 0.030 |
Why?
|
Pelvis | 1 | 2016 | 730 | 0.030 |
Why?
|
Leukemia Virus, Murine | 1 | 2011 | 117 | 0.030 |
Why?
|
Texas | 1 | 2012 | 392 | 0.020 |
Why?
|
Work Schedule Tolerance | 1 | 2015 | 565 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2015 | 780 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16689 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2021 | 5524 | 0.020 |
Why?
|
Inpatients | 1 | 2002 | 2518 | 0.020 |
Why?
|
Organizational Policy | 1 | 2013 | 429 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2012 | 392 | 0.020 |
Why?
|
Income | 1 | 2019 | 1913 | 0.020 |
Why?
|
Catechol O-Methyltransferase | 1 | 2011 | 245 | 0.020 |
Why?
|
Workload | 1 | 2015 | 850 | 0.020 |
Why?
|
Social Values | 1 | 2010 | 224 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3586 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2266 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9734 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3589 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2019 | 2576 | 0.020 |
Why?
|
Registries | 1 | 2004 | 8089 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2015 | 1425 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 2988 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6364 | 0.020 |
Why?
|
Breast | 1 | 2016 | 1969 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2005 | 25625 | 0.020 |
Why?
|
Insurance, Health | 1 | 2019 | 2494 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14557 | 0.020 |
Why?
|
Culture | 1 | 2010 | 633 | 0.020 |
Why?
|
Adnexa Uteri | 1 | 2005 | 45 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3158 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2011 | 3129 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8428 | 0.020 |
Why?
|
Program Development | 1 | 2011 | 1316 | 0.020 |
Why?
|
Estradiol | 1 | 2011 | 2020 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5179 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 21827 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11524 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2009 | 63114 | 0.010 |
Why?
|
Program Evaluation | 1 | 2011 | 2488 | 0.010 |
Why?
|
Pregnancy, High-Risk | 1 | 2001 | 120 | 0.010 |
Why?
|
Adolescent | 2 | 2012 | 85781 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12245 | 0.010 |
Why?
|
Maternal Mortality | 1 | 2001 | 310 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23403 | 0.010 |
Why?
|
Maternal Age | 1 | 2001 | 802 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2003 | 1641 | 0.010 |
Why?
|
Communication | 1 | 2012 | 3749 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53288 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
Age Distribution | 1 | 2003 | 2902 | 0.010 |
Why?
|
Infant Mortality | 1 | 2001 | 754 | 0.010 |
Why?
|
Biomedical Research | 1 | 2011 | 3309 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9438 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18370 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7279 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81183 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168757 | 0.010 |
Why?
|
Young Adult | 1 | 2012 | 56430 | 0.000 |
Why?
|
Incidence | 1 | 2003 | 20947 | 0.000 |
Why?
|
Risk Assessment | 1 | 2003 | 23338 | 0.000 |
Why?
|
Risk Factors | 1 | 2001 | 72290 | 0.000 |
Why?
|
Concepts
(208)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(50)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_